Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III.
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 04 Apr 2013 Status changed from active, no longer recruiting to completed.
- 04 Apr 2013 Results published in the New England Journal of Medicine.
- 06 Jun 2012 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History